Ocular enucleation in a patient with severe classic hemophilia A.
A 27-year-old man with severe classic hemophilia A (antihemophilic globulin level: 1.5% of normal) had blunt trauma to his left eye that produced a corneoscleral laceration with prolapse of the intraocular contents. His left eye was enucleated under management with factor VIII replacement. This consisted of sufficient cryoprecipitate to increase the calculated circulating factor VIII level to 125%, sufficient factor VIII every 12 hours to increase peak postinfusion levels from 100 to 120%, and to maintain minimum levels of 30% immediately before infusion. Because he had developed a gingival hematoma when he was placed on epsilon amino caproic acid after only one day of factor VIII replacement following extraction of mandibular molars, we continued the high level of factor VIII replacement for five days and then began antifibrinolytic epsilon amino caproic acid therapy. His surgical and postoperative course were uneventful on this regimen.
D000328:Adult; D015119:Aminocaproic Acid / Q000008:administration & dosage; D003450:Cryoglobulins / Q000008:administration & dosage; D005131:Eye Injuries / Q000601:surgery*; D005137:Eye, Artificial; D005169:Factor VIII / Q000008:administration & dosage / Q000032:analysis; D006467:Hemophilia A / Q000097:blood / Q000150:complications*; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D008297:Male; D013508:Ophthalmologic Surgical Procedures
D003450:Cryoglobulins; D005169:Factor VIII; D015119:Aminocaproic Acid